Haiwei Du

452 total citations
30 papers, 262 citations indexed

About

Haiwei Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Haiwei Du has authored 30 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Haiwei Du's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Research Studies (4 papers). Haiwei Du is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Research Studies (4 papers). Haiwei Du collaborates with scholars based in China, United States and Japan. Haiwei Du's co-authors include Xiaojie Yang, Guofeng Zhu, Peiqi Yin, Qi Jin, Leiliang Zhang, Qinghai Chen, Peng Jin, Xiaoyan Ji, Ting Zhang and Haoxiang Su and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Haiwei Du

26 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiwei Du China 10 97 94 94 63 44 30 262
Javier Torres-Jiménez Spain 8 46 0.5× 60 0.6× 80 0.9× 60 1.0× 23 0.5× 21 252
Ioannis P. Trontzas Greece 11 88 0.9× 97 1.0× 153 1.6× 20 0.3× 27 0.6× 32 338
Katjana Schwab Germany 12 53 0.5× 74 0.8× 142 1.5× 28 0.4× 22 0.5× 23 285
Antoine Desîlets Canada 8 38 0.4× 135 1.4× 172 1.8× 23 0.4× 20 0.5× 30 278
Nobuya Daitoku Japan 10 64 0.7× 59 0.6× 183 1.9× 15 0.2× 49 1.1× 18 284
Matthew Brown United Kingdom 9 74 0.8× 55 0.6× 109 1.2× 17 0.3× 50 1.1× 18 294
Nisha R. Pawar United States 6 30 0.3× 117 1.2× 72 0.8× 25 0.4× 45 1.0× 8 267
Ana Rodrigues Portugal 8 66 0.7× 74 0.8× 76 0.8× 18 0.3× 44 1.0× 33 226
Qingsong Lei China 9 78 0.8× 141 1.5× 32 0.3× 18 0.3× 69 1.6× 12 322
Kai Mi China 5 91 0.9× 47 0.5× 99 1.1× 16 0.3× 19 0.4× 8 326

Countries citing papers authored by Haiwei Du

Since Specialization
Citations

This map shows the geographic impact of Haiwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiwei Du more than expected).

Fields of papers citing papers by Haiwei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiwei Du. The network helps show where Haiwei Du may publish in the future.

Co-authorship network of co-authors of Haiwei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Haiwei Du. A scholar is included among the top collaborators of Haiwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiwei Du. Haiwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Haiwei, et al.. (2025). Benefit of adjuvant chemotherapy for resected stage I lung cancer with spread through air spaces: a systematic review and meta-analysis. European Journal of Surgical Oncology. 51(8). 110104–110104.
3.
Xiang, Chan, Ke Chen, Ruiying Zhao, et al.. (2024). Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation. Modern Pathology. 37(4). 100451–100451. 9 indexed citations
4.
Fan, Feifei, Guozhong Jiang, Juan Lv, et al.. (2024). Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients. Cancer Medicine. 13(19). e70078–e70078. 1 indexed citations
5.
Han, Rui, Yimin Zhang, Tianhu Wang, et al.. (2023). Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer. Cancer Science. 114(6). 2569–2583. 13 indexed citations
6.
Xue, Pei, Yanfei Shao, Xueliang Zhou, et al.. (2023). Abstract 1037: Circulating tumor DNA-based molecular residual disease predicts relapse in patients with resectable gastric cancer. Cancer Research. 83(7_Supplement). 1037–1037. 1 indexed citations
7.
Zhang, Yongchang, Rui Han, Yubo Wang, et al.. (2022). The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer. Cancer Medicine. 12(5). 5603–5614. 4 indexed citations
8.
9.
Cui, Qian, Hongmei Wu, Haiwei Du, et al.. (2022). Comprehensive genomic profiling and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the stomach and parotid gland. Annals of Translational Medicine. 10(1). 13–13. 2 indexed citations
10.
Liu, Zimin, Xiaoxiao Li, Ning Liu, et al.. (2021). HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 147(5). 1315–1324. 9 indexed citations
11.
Zhao, Lingling, et al.. (2021). Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review. Frontiers in Oncology. 11. 605853–605853. 3 indexed citations
12.
Chen, Xi, Yan‐Ping Zhu, Zhang Bao, et al.. (2021). Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients. Cancer Immunology Immunotherapy. 70(12). 3513–3524. 31 indexed citations
13.
Jiao, Xiao‐Dong, Ke Liu, Ying Wu, et al.. (2021). HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma. The Oncologist. 26(9). 717–721. 4 indexed citations
14.
Wu, Di, Yuancai Xie, Ting Hou, et al.. (2020). The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of Translational Medicine. 8(24). 1642–1642. 9 indexed citations
15.
Li, Chunyan, Fan Liu, Shenghua Liu, et al.. (2020). Elevated myocardial SORBS2 and the underlying implications in left ventricular noncompaction cardiomyopathy. EBioMedicine. 53. 102695–102695. 21 indexed citations
16.
Du, Haiwei, Shenghua Liu, Chunyan Li, & Yingjie Wei. (2019). Comparative proteomics analysis of myocardium in left ventricular non-compaction cardiomyopathy. Acta Biochimica et Biophysica Sinica. 51(6). 652–654. 2 indexed citations
17.
Chen, Qinghai, et al.. (2018). Management of difficult or failed biliary access in initial ERCP: A review of current literature. Clinics and Research in Hepatology and Gastroenterology. 43(4). 365–372. 21 indexed citations
18.
Du, Haiwei, et al.. (2018). Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma. Frontiers in Pharmacology. 9. 884–884. 25 indexed citations
19.
Du, Haiwei, Peiqi Yin, Xiaojie Yang, et al.. (2015). Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65). Scientific Reports. 5(1). 14302–14302. 52 indexed citations
20.
Jin, Peng, Xiaoyan Ji, Xiaodong Song, et al.. (2015). A review of 42 cases of intestinal pseudo-obstruction in patients with systemic lupus erythematosus based on case reports. Human Immunology. 76(9). 695–700. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Torres-Jiménez Breakdown of academic impact, for papers by Ioannis P. Trontzas Breakdown of academic impact, for papers by Katjana Schwab Breakdown of academic impact, for papers by Antoine Desîlets Breakdown of academic impact, for papers by Nobuya Daitoku Breakdown of academic impact, for papers by Matthew Brown Breakdown of academic impact, for papers by Nisha R. Pawar Breakdown of academic impact, for papers by Ana Rodrigues Breakdown of academic impact, for papers by Qingsong Lei Breakdown of academic impact, for papers by Kai Mi
Rankless by CCL
2026